TUSA, IGNAZIA
 Distribuzione geografica
Continente #
EU - Europa 1.852
NA - Nord America 1.321
AS - Asia 332
AF - Africa 9
Totale 3.514
Nazione #
US - Stati Uniti d'America 1.306
PL - Polonia 818
RU - Federazione Russa 444
IT - Italia 266
IE - Irlanda 137
SE - Svezia 89
CN - Cina 87
HK - Hong Kong 77
SG - Singapore 69
JO - Giordania 33
IN - India 32
GB - Regno Unito 28
DE - Germania 22
FI - Finlandia 20
VN - Vietnam 20
CA - Canada 14
BE - Belgio 9
CI - Costa d'Avorio 8
JP - Giappone 6
CH - Svizzera 5
FR - Francia 4
ID - Indonesia 3
NL - Olanda 3
PH - Filippine 2
TW - Taiwan 2
UA - Ucraina 2
AT - Austria 1
BY - Bielorussia 1
ES - Italia 1
KR - Corea 1
LY - Libia 1
MX - Messico 1
PT - Portogallo 1
RO - Romania 1
Totale 3.514
Città #
Warsaw 818
Fairfield 180
Chandler 152
Dublin 132
Florence 111
Ashburn 106
Seattle 96
Woodbridge 88
Cambridge 75
Ann Arbor 65
Houston 65
Wilmington 61
Singapore 53
Hong Kong 52
Lawrence 43
Altamura 42
Princeton 31
Beijing 25
Mumbai 25
Boston 23
Buffalo 23
San Diego 19
Shanghai 17
Dong Ket 16
Santa Clara 16
Moscow 15
Kent 14
Ottawa 12
Boardman 11
Rome 11
Brussels 9
Abidjan 8
London 8
Milan 7
Prato 7
Medford 6
Turin 6
Bern 5
Guangzhou 5
Phoenix 5
Pune 5
Renton 5
Cagliari 4
Helsinki 4
Andover 3
Detroit 3
Falls Church 3
Lappeenranta 3
Liverpool 3
Malang 3
Menlo Park 3
Munich 3
Norwalk 3
Tokyo 3
Anghiari 2
Branford 2
Castelliri 2
Foggia 2
Islington 2
Kaohsiung City 2
Karlskrona 2
Karlsruhe 2
Los Angeles 2
Nuremberg 2
Redwood City 2
Rubano 2
San Juan 2
Siena 2
Silea 2
Toronto 2
Trumbull 2
West Jordan 2
Zhengzhou 2
Acireale 1
Albignasego 1
Atlanta 1
Austin 1
Azcapotzalco 1
Baotou 1
Bologna 1
Bradford 1
Bremen 1
Busto Arsizio 1
Castel Volturno 1
Certaldo 1
Chennai 1
Costa Mesa 1
Cuneo 1
Dearborn 1
Dongyang 1
Fremont 1
Fuente Del Maestre 1
Gallatin 1
Gunzenhausen 1
Heidelberg 1
Hillsboro 1
Hrodna 1
Hyderabad 1
Jacksonville 1
Jiaxing 1
Totale 2.576
Nome #
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 262
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 250
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 249
ERK5 is activated by oncogenic BRAF and promotes melanoma growth 241
Role of ERK5/BMK1 in the survival, proliferation and stemness of chronic myeloid leukemia cells in hypoxia 215
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 210
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 196
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 178
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 144
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 140
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 124
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 119
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 95
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 88
Non-thermal effects of 2.45 GHz microwaves on spindle assembly, mitotic cells and viability of Chinese hamster V-79 cells 85
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 75
Hepatocyte-specific deletion of HIF2α prevents NASH-related liver carcinogenesis by decreasing cancer cell proliferation 74
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 73
Playing the Whack-A-Mole Game: ERK5 Activation Emerges Among the Resistance Mechanisms to RAF-MEK1/2-ERK1/2- Targeted Therapy 72
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 72
Anti-β4 integrin autoantibodies in patients with mucous membrane pemphigoid: a retrospective analysis from a tertiary centre in Italy 70
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 66
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 65
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 62
Spontaneous and bleomycin-induced chromosome damage in non cancer thyroid patients. 61
ERK5-INHIBITION AS A NOVEL APPROACH TO TARGET CML STEM CELLS 56
ERK5 inhibition elicits cellular senescence in human melanoma cells 56
Positive correlation of HIF2α and SERPINB3 in human hepatocellular carcinoma: selectivity and prognostic implications 41
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress 37
Importin subunit beta‐1 mediates ERK5 nuclear translocation, and its inhibition synergizes with ERK5 kinase inhibitors in reducing cancer cell proliferation 35
Sphingosine 1-phosphate elicits a ROS-mediated proinflammatory response in human endometrial stromal cells via ERK5 activation 33
Latent-transforming growth factor β-binding protein 1/Transforming growth factor β1 complex drives antitumoral effects upon ERK5 targeting in melanoma 31
Targeting MAPK in Cancer 2.0 21
ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2 19
Totale 3.615
Categoria #
all - tutte 10.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.637


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020495 0 0 0 43 73 57 63 84 59 47 57 12
2020/2021439 32 58 8 62 22 38 26 28 48 70 24 23
2021/2022318 32 15 23 20 17 10 25 14 36 23 42 61
2022/2023676 52 117 44 28 53 110 88 56 90 9 13 16
2023/2024311 12 22 32 14 14 37 21 84 9 18 32 16
2024/2025639 89 194 117 239 0 0 0 0 0 0 0 0
Totale 3.615